Corvex, Inc. (MOVE) — SEC Filings
Corvex, Inc. (MOVE) — 36 SEC filings. Latest: 8-K (Apr 9, 2026). Includes 22 8-K, 5 10-Q, 3 DEF 14A.
View Corvex, Inc. on SEC EDGAR
Overview
Corvex, Inc. (MOVE) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 9, 2026: Corvex, Inc. filed an 8-K report on April 9, 2026, to disclose other events that occurred on April 7, 2026. The filing includes standard documents like the current report and XBRL data files.
Sentiment Summary
Across 36 filings, the sentiment breakdown is: 8 bearish, 28 neutral. The dominant filing sentiment for Corvex, Inc. is neutral.
Filing Type Overview
Corvex, Inc. (MOVE) has filed 22 8-K, 3 DEF 14A, 5 10-Q, 1 8-K/A, 2 10-K, 1 10-K/A, 1 SC 13G, 1 SC 13G/A with the SEC between Apr 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (36)
Risk Profile
Risk Assessment: Of MOVE's 31 recent filings, 9 were flagged as high-risk, 10 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $80K |
| Net Income | $-4.029M |
| EPS | $-4.73 |
| Debt-to-Equity | N/A |
| Cash Position | $2.000M |
| Operating Margin | -3238.8% |
| Total Assets | $5.557M |
| Total Debt | $7.258M |
Key Executives
- John Mastrototaro
- Jeremy Cogan
- Chief Executive Officer
Industry Context
Movano Inc. operates in the wearable technology and digital health sector, focusing on developing advanced sensor technology for health monitoring. This industry is characterized by rapid innovation, significant R&D investment, and a competitive landscape with both established players and emerging startups. Regulatory approvals (e.g., FDA) are often critical for market entry and commercialization of health-related devices.
Top Tags
material-agreement (4) · delisting (4) · financials (4) · corporate-action (3) · 8-k (3) · SEC Filing (3) · 10-Q (3) · 8-K (2) · Shareholder Meeting (2) · Corporate Governance (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| CIK Number | 0001734750 | Identifies Corvex, Inc. in SEC filings. |
| Filing Date | 2026-04-09 | Date the 8-K report was accepted by the SEC. |
| Proposed Authorized Common Stock | 2,500,000,000 | A 400% increase from the current 500,000,000 shares, indicating significant potential for future equity issuance and dilution. |
| Additional Incentive Plan Shares | 500,000 | Increase in shares reserved for the Amended and Restated 2019 Omnibus Incentive Plan, impacting employee compensation and potential dilution. |
| Common Stock Outstanding | 834,857 | Number of common shares outstanding as of the November 10, 2025 record date, against which the 'more than 20%' issuance will be measured. |
| Special Meeting Time | 1:00 p.m. Pacific Time | Time for the virtual special meeting on December 16, 2025, where critical proposals will be voted on. |
| ChEF Purchase Agreement Date | November 6, 2025 | Date Movano entered into the ChEF Purchase Agreement with Chardan Capital Markets LLC, triggering the Nasdaq Listing Rule 5635(d) requirement. |
| Net Loss (Q3 2025) | $4.029M | Decreased from $7.201M in Q3 2024, indicating improved operational efficiency but still a significant loss. |
| Revenue (Q3 2025) | $80K | Increased from $50K in Q3 2024, showing slight growth in product sales. |
| Cash and Cash Equivalents (Sept 30, 2025) | $2.000M | A sharp decline from $7.902M at Dec 31, 2024, highlighting severe liquidity issues. |
| Accumulated Deficit (Sept 30, 2025) | $160.539M | Increased from $148.107M at Dec 31, 2024, indicating continued unprofitability. |
| Bridge Loan (Related Party) | $2.965M | New debt incurred, reflecting immediate need for capital. |
| Reverse Stock Split | 1-for-10 | Implemented on October 10, 2025, to regain Nasdaq compliance. |
| Equity Facility | $1.0B | New financing arrangement with Chardan Capital Markets LLC, critical for future funding. |
| Series A Financing | $3.0M | Equity capital raised in November 2025, providing short-term liquidity. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Corvex, Inc. (MOVE)?
Corvex, Inc. has 36 recent SEC filings from Apr 2024 to Apr 2026, including 22 8-K, 5 10-Q, 3 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of MOVE filings?
Across 36 filings, the sentiment breakdown is: 8 bearish, 28 neutral. The dominant sentiment is neutral.
Where can I find Corvex, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Corvex, Inc. (MOVE) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Corvex, Inc.?
Key financial highlights from Corvex, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for MOVE?
The investment thesis for MOVE includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Corvex, Inc.?
Key executives identified across Corvex, Inc.'s filings include John Mastrototaro, Jeremy Cogan, Chief Executive Officer.
What are the main risk factors for Corvex, Inc. stock?
Of MOVE's 31 assessed filings, 9 were flagged high-risk, 10 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Corvex, Inc.?
Forward guidance and predictions for Corvex, Inc. are extracted from SEC filings as they are enriched.